Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minhai-HIB Vaccine in Healthy Children
NCT02560272Phase 3Unknown
- Sponsor
- Beijing Minhai Biological
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Haemophilus influenzae type b conjugate vaccine in Haemophilus influenzae type b infection (Hib), sponsored by Beijing Minhai Biological. Status: unknown.
02
Drugs
Haemophilus influenzae type b conjugate vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT02560272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560272.